BioSig Technologies, Inc. (BSGM)
NASDAQ: BSGM · IEX Real-Time Price · USD
1.720
-0.060 (-3.37%)
May 3, 2024, 10:08 AM EDT - Market open
BioSig Technologies Revenue
In the year 2023, BioSig Technologies had annual revenue of $18.00K, a decrease of -93.71%. Revenue in the quarter ending December 31, 2023 was $12.00K, a -91.11% decrease year-over-year.
Revenue (ttm)
$18.00K
Revenue Growth
-93.71%
P/S Ratio
1,087.47
Revenue / Employee
$4,500
Employees
4
Market Cap
19.56M USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 18.00K | -268.00K | -93.71% |
Dec 31, 2022 | 286.00K | -155.00K | -35.15% |
Dec 31, 2021 | 441.00K | - | - |
Dec 31, 2020 | 0 | - | - |
Dec 31, 2019 | 0 | - | - |
Dec 31, 2018 | 0 | - | - |
Dec 31, 2017 | 0 | - | - |
Dec 31, 2016 | 0 | - | - |
Dec 31, 2015 | 0 | - | - |
Dec 31, 2014 | 0 | - | - |
Dec 31, 2013 | 0 | - | - |
Dec 31, 2012 | 0 | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
ATI Physical Therapy | 699.02M |
MEI Pharma | 72.65M |
T2 Biosystems | 7.19M |
Orgenesis | 530.00K |
AIM ImmunoTech | 202.00K |
BSGM News
- 2 days ago - BioSig Technologies, Inc. Appoints Mr. Anthony Amato to Position of Chief Executive Officer, Effective Immediately - GlobeNewsWire
- 4 weeks ago - BioSig Engages Consulting Firm for Business Model Strategies - GlobeNewsWire
- 2 months ago - BioSig Announces Reduction of its Workforce - GlobeNewsWire
- 3 months ago - BioSig's PURE EP™ Platform with New Near Field Tracking Algorithm Surpasses 100 Patient Cases - GlobeNewsWire
- 3 months ago - BioSig Announces Reverse Stock Split - GlobeNewsWire
- 3 months ago - BioSig Announces Cost Reductions to Improve its Financial Standing and Shifts its Core Strategy - GlobeNewsWire
- 5 months ago - BioSig Issues Letter to Shareholders Detailing Technology Innovations and Strategic Focus for 2024 - GlobeNewsWire
- 6 months ago - BioSig Announces $2.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules - GlobeNewsWire